[Influence of long-term moxonidine (psysiotens) monotherapy on neuropsychological status and brain perfusion in elderly patients with arterial hypertension].
Martynov
A I
AI
Ostroumova
O D
OD
Korsakova
N K
NK
Sergienko
V B
VB
Varako
N A
NA
Bagramova
Iu A
IuA
D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D001921:Brain / Q000098:blood supply* / Q000000981:diagnostic imaging / Q000378:metabolism*; D003071:Cognition / Q000187:drug effects*; D003704:Dementia / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D005260:Female; D005625:Frontal Lobe / Q000098:blood supply / Q000000981:diagnostic imaging / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007093:Imidazoles / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D013995:Time; D015899:Tomography, Emission-Computed, Single-Photon
D000959:Antihypertensive Agents; D007093:Imidazoles; C043482:moxonidine